Table 1.

Summary of demographic and clinical data and MRI and network variables.

	HC	MS	CIMS	CPMS
Participants (M/F)	10/12	24/44	7/13	16 / 30
Age (years)	36.5 ± 10.8	46.7 ± 11.0	50.3 ± 10.6	45.3 ± 11.0
Disease duration (years)	n.a.	16.7 ± 10.4	21.9 ± 12.6	14.6 ± 8.5
Median EDSS (range)	n.a.	4.5 (1–8.5)	6.0 (1–8.5)	2.0 (1–7.5)
SDMT	62.6 ± 10.8	47.1 ± 12.5	32.1 ± 5.9	53.6 ± 8.3
HADS-A	5.4 ± 4.2	6.6 ± 4.0	6.9 ± 4.0	6.3 ± 3.8
HADS-D	3.0 ± 4.0	5.9 ± 3.6	6.8 ± 3.3	5.4 ± 3.6
NART-predict	108.9 ± 9.3	107.4 ± 10.8	103.2 ± 9.8	109.2 ± 10.8
BPF	0.82 ± 0.02	0.80 ± 0.02	0.79 ± 0.02	0.80 ± 0.02
WM-LL (ml)	n.a.	8.08 ± 9.74	11.85 ± 14.02	6.34 ± 6.72
WM-FA	0.36 ± 0.04	0.24 ± 0.02	0.23 ± 0.03	0.24 ± 0.02
GE(CBL-DMN)	0.34 ± 0.04	0.29 ± 0.03	0.28 ± 0.04	0.29 ± 0.02
GE(DMN)	0.36 ± 0.04	0.29 ± 0.04	0.27 ± 0.04	0.30 ± 0.03
GE(CBL)	0.13 ± 0.02	0.12 ± 0.01	0.11 ± 0.01	0.12 ± 0.01

Results are shown as mean ± standard deviation unless otherwise reported.